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S U M M A R Y
Mass gatherings at major international sporting events put millions of international travelers and local
host-country residents at risk of acquiring infectious diseases, including locally endemic infectious
diseases. The mosquito-borne Zika virus (ZIKV) has recently aroused global attention due to its rapid
spread since its ﬁrst detection in May 2015 in Brazil to 22 other countries and other territories in the
Americas. The ZIKV outbreak in Brazil, has also been associated with a signiﬁcant rise in the number of
babies born with microcephaly and neurological disorders, and has been declared a ‘Global Emergency
by the World Health Organization. This explosive spread of ZIKV in Brazil poses challenges for public
health preparedness and surveillance for the Olympics and Paralympics which are due to be held in Rio
De Janeiro in August, 2016. We review the epidemiology and clinical features of the current ZIKV
outbreak in Brazil, highlight knowledge gaps, and review the public health implications of the current
ZIKV outbreak in the Americas. We highlight the urgent need for a coordinated collaborative response for
prevention and spread of infectious diseases with epidemic potential at mass gatherings events.
 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Mass gatherings and transmission of infectious diseases
Sporting events attract millions of international travelers and
residents from the host country. These mass gatherings of people
are put at risk of acquiring imported and locally prevalent
infectious diseases.1,2 Brazil is to host the 2016 Olympic and
Paralympic Games in Rio De Janeiro in August 2016 3 where
millions of people from within Brazil and from all over the world,
are expected to attend. Recent media and World Health* Corresponding author.
E-mail address: eskildp@dadlnet.dk (E. Petersen).
http://dx.doi.org/10.1016/j.ijid.2016.02.001
1201-9712/ 2016 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Organization (WHO) attention has focused on the unexplained
rapid spread of the mosquito-borne Zika Virus (ZIKV) across South
and Central America and the Caribbean Islands.4 On February 1st
2016 the WHO announced that the ZIKV outbreak constitutes a
‘Public Health Emergency of International Concern’.5 The term ‘public
health emergency of international concern (PHEIC)’ is deﬁned in
the International Health Regulations as ‘‘an extraordinary event
which is determined to constitute a public health risk to other
States through the international spread of disease and to
potentially require a coordinated international response’’.
The ﬁrst ever case of ZIKV disease in Brazil was reported in May
2015,6 and since then, the virus has rapidly spread within Brazil7
and across 22 other countries and territories in the region.8,9 Theciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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associated with a large rise in the number of babies born with
microcephaly and other neurological complications.4,5,7,10–12 The
rapid spread of ZIKV in Brazil and the Americas is also of great
concern since it joins the growing list of re-emerging infectious
diseases13, and its epidemic potential poses challenges for public
health preparedness and surveillance for the 2016 Olympics and
Paralympic Games. We review the epidemiology and clinical
features of the current ZIKV outbreak in Brazil, highlight
knowledge gaps, and highlight the need for enhanced public
health preparedness for the 2016 Olympic Games.
2. ZIKV epidemiology and global spread
ZIKV is a single stranded RNA arbovirus member of the genus
Flavivirus and is related to other mosquito-borne viruses such as
Dengue, Yellow Fever, Japanese B encephalitis, and West Nile Fever
viruses. ZIKV was named as such because it was ﬁrst identiﬁed in a
rhesus monkey in the Zika Forest of Uganda in 1947.14 ZIKV was
later found in humans with febrile illnesses in West Africa15 in
1954. It then to spread to Indonesia16, Micronesia17, Thailand,18
the Philippines,19 French Polynesia,20 and Easter Island-South
Paciﬁc in 2014.21 ZIKV was not documented on mainland South
America until the ﬁrst report of autochthonous transmission in
Brazil in May 2015. The conclusion at that time was that ZIKV was
introduced into Brazil during the 2014 World Cup Football.6 This
was not supported due to the fact that no Paciﬁc countries with
documented ZIKV had competed in the World Cup competition.
However, Paciﬁc countries had participated in the August
2014 Va’a World Sprints canoe championship which was held in
Rio de Janeiro, suggesting that introduction of ZIKV into Brazil
could have occurred then.23,23 Another possibility was the
introduction of ZIKV to Brazil by travelers from Chile.24 Since its
introduction into Brazil in May 2015, ZIKV has subsequently
spread rapidly across Brazil and the Americas. As of January 28th
2016, autochthonous cases of ZIKV infection have been reported
from 26 countries in the Americas: Barbados, Bolivia, Brazil,
Colombia, Curac¸ao, Dominican Republic, Ecuador, El Salvador,
French Guiana, Guadeloupe, Guatemala, Guyana, Haiti, Honduras,
Martinique, Mexico, Nicaragua, Panama, Paraguay, Puerto Rico,
Saint Martin, Suriname, Venezuela, Virgin island.11 No autochtho-
nous ZIKV transmission has been reported from EU countries, and a
heightened state of global alert is in place in Europe and USA to
screen for ZIKV in travelers with fever returning from ZIKV-
endemic countries.4,5
The ﬁrst travel-associated ZIKV disease case among U.S. travelers
was reported in 2007. From 2007 to 2014, a total of 14 returning U.S.
travelers had positive ZIKV testing performed at UC-Centers for
Diseases Control (CDC). In 2015 and 2016 at least eight U.S. travelers
have had positive ZIKV testing performed at CDC.25
3. Mode of transmission of ZIKV
The primary mode of transmission of ZIKV between humans is
through the bite of an infected female mosquito of the Aedes
species.4,5 Apart from mosquitos, other non-vector means of
transmission of ZIKV have been suggested: a) via sexual
intercourse26,27, b) blood transfusions28, c) perinatal transmission
from mother to foetus at time of delivery.29–31
Although it is possible that ZIKV could be passed from mother to
fetus during any trimester of pregnancy30, limited data from one
study31 has indicated that ZIKV maternal infection in the ﬁrst
trimester might carry a greater risk of fetal microcephaly. Of
35 infants with microcephaly, 26 (74%) of the mothers reported
having had a rash; 21 in the ﬁrst trimester, 5 in the second
trimester. Other fetal brain abnormalities that have been reportedin association with clinical maternal ZIKV infection are ventricu-
lomegaly, cell migration abnormalities, and congenital contrac-
tures secondary to central or peripheral nervous system
involvement.29–31 There have been no reports yet of ZIKV post-
natal transmission to babies through breastfeeding. Further
studies are required to delineate the importance of these modes
of transmission.
3.1. Mosquito-borne ZIKV transmission
Aedes spp mosquitoes are present throughout the tropics. They
are known to transmit other important arboviruses that affect
humans such as Chikungunya Virus, Dengue Virus and Yellow
Fever Virus.32–37 The main vector associated with transmission of
ZIKV is Aedes aegypti. Transmission can also occur via other Aedes
species38 such as: Ae.albopictus, Ae.africanus, Ae.luteocephalus,
Ae.vitattus, Ae.furcifer, Ae.hensilii and Ae.apicoargenteus. Aedes
aegypti lives and breeds near people and their homes, laying their
eggs in stagnant water which collects in puddles, buckets, ﬂower
pots, empty cans and other containers. They bite humans mainly
during daytime, either outside or inside their houses. Aedes aegypti
mosquitoes are widely distributed in the Americas (except for
Chile) and the suitable climatic breeding conditions is partly
responsible for the current ZIKV epidemic, with over a million
cases reported.4,5 Aedes albopictus39 is found in the USA40 as far
north as New York and Chicago, and in parts of southern Europe. It
is expected that the current ZIKV transmission will increase
throughout the Americas with possibility of local transmission
within the USA. Since the Aedes mosquito species that spread ZIKV
are found in many locations throughout the world, it is likely that
outbreaks will spread to new countries.
3.2. Sexual transmission
ZIKV has been isolated from semen26,27 and possible sexual
transmission has been reported.26 Studies are needed to assess
how frequently and for how long ZIKV persists in semen (or other
privileged sites in the body) and whether precautions to prevent
sexual transmission of ZIKV are warranted.
3.3. Blood transfusion and transmission of ZIKV
Given that the majority (80%) of persons with ZIKV infection are
asymptomatic4 and among them are blood donors, transmission of
ZIKV via blood transfusion is of concern.28 It has a parallel in the
introduction of West Nile Virus in the United States and Canada,
which led to the need for screening of donated blood.41 The
outbreak of Chikungunya Virus (CKV) which started in Reunion42
and spread throughout Asia, also prompted screening of blood
products. After the introduction of CKV in Italy, systematic
screening by blood banks was considered, but a laboratory test
for routine testing was not available43 so blood donations from
people living in the affected municipalities were discontinued. A
21-day deferral policy was introduced nationwide for blood donors
who had visited the affected areas, even for a few hours. The pre-
donation questionnaire was modiﬁed for an early detection of CKV
infections. All stocked blood components collected from donors
living in the affected area, after the identiﬁcation of the ﬁrst case,
even those already delivered to the pharmaceutical industry, were
eliminated. The impact of the CKV outbreak in Italy was later
evaluated44 with the conclusion that ‘‘Even a relatively small
outbreak in Italy resulted in considerable adverse impact on blood
collections and economic consequence’’. It is likely that blood
transfusion related infection does occur in ZIKV endemic areas. To
prevent blood transfusion related ZIKV infection, blood donations
must also be screened for ZIKV.
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4.1. Symptoms and signs
The incubation period is not known but the ﬁrst symptoms of
ZIKV disease can develop between 3 to 12 days after the mosquito
bite and they resolve within 7 days in most cases. ZIKV causes
predominantly a mild illness and therefore over 80% of cases may
go unnoticed.4 In one in ﬁve cases who are symptomatic the
clinical spectrum of disease overlaps with that caused by other
arbovirus infections such as Dengue and Chikungunya.4,9,45 These
include fever, malaise, skin rashes (maculo-papular rash is
considered immune mediated), conjunctivitis (red eye), muscle
and joint pain and headache. These symptoms are usually mild and
last for between 2 to 7 days.4 Severe disease is uncommon and
most cases do not require hospitalization.
4.2. Diagnosis
The US-CDC has recommended speciﬁc diagnostic algorithms for
ZIKV diagnosis in adults and children.46,47 The diagnosis of ZIKV can
be conﬁrmed by ampliﬁcation (RT-PCR) of viral genome. Commer-
cial diagnostic tests for ZIKV detection are under development but
not yet available. The ZIKV outbreak in the Americas has generated
signiﬁcant interest in development of new rapid diagnostics, drugs
and vaccines for ZIKV. Ongoing efforts in diagnostics include: a)
Standardizing PCR methods for comparative purposes, b) Develop-
ment of rapid speciﬁc serologic tests for clinical and epidemiological
studies, c) Determining the role of viral load in pathogenesis and in
utero transmission and d) Validating the use of non-blood speci-
mens. Due of the kinetics of the ZIKV viraemia, the clinical utility of
RT-PCR is limited to testing blood samples collected less than one
week after onset of symptoms. Since ZIKV virus is excreted for a
longer time in urine, such samples can be usefully tested up to three
weeks after onset. RT-PCR can also be performed on amniotic ﬂuid,
although the positive and negative predictive values for either fetal
infection or development of fetal pathology are uncertain. For
detection of past or recent infection, serum antibody testing is not
reliable because of extensive cross-reactivity against Dengue Fever
and Yellow fever, two diseases which are co-located geographically.
Yellow fever have wide vaccine coverage. This diagnostic limitation
to demonstrating seroconversion to ZIKV in pregnancy hampers the
retrospective investigations into the temporal relationship between
the Brazilian epidemic and increase in congenital malformations.
4.3. Congenital malformations and Neurological complications
During the large ZIKV outbreaks in 2013 in French Polynesia48
and in Brazil7 in 2015, neurological complications such as the
Guillain Barre´ syndrome were reported. According to the Ministry of
Health of Brazil epidemiological update49 of 27th January, 2016,
there were 4,180 reported cases of microcephaly with suspected
associated with ZIKV infection, of which 732 (17.5%) have been
investigated and classiﬁed. Of the 270/732 (37%) conﬁrmed cases
with central nervous system malformations, 6/270 (2.2%) were
positive for ZIKV infection. The risk of developing a microcephalic
baby following ZIKV infection in pregnancy cannot be quantiﬁed and
will require case control studies. ZIKV testing in newborns has
several challenges and case controlled studies using more sensitive
diagnostics are required. RT-PCR tests may not detect ZIKV RNA in a
newborn who acquired ZIKV infection in utero if the period of
viremia has passed.
Serologic tests for ZIKV can often be falsely positive because of
cross-reacting antibodies against other endemic ﬂaviviruses such as
Dengue Fever and Yellow Fever. Plaque-reduction neutralization
testing (PRNT) can be performed to measure virus-speciﬁcneutralizing antibodies to ZIKV, but neutralizing antibodies may
still yield cross-reactive results in newborns due to maternal
antibodies that were transferred to the infant. Cases of microcephaly
following ZIKV infection have not been reported from Southeast
Asia, but could easily have been missed due to lack of clinical
awareness, and because investigation for ZIKV is not usually part of
the investigations for a short, febrile illness. Interim Guidelines for
the Evaluation and Testing of Infants with possible congenital ZIKV
Infection have been recently introduced by the US-CDC.47
5. Knowledge gaps on the current Brazil ZIKV outbreak
It is not clear what are the factors underlying the rapidity and
intensity of ongoing ZIKV outbreak in Brazil. Furthermore the
association of ZIKV with microcephaly and neurological disorders
requires further study.50
One hypothesis is that the ZIKV has undergone recombination
in nature and that a loss of the N154 glycosylation site in the
envelope protein as a possible adaptive response to the Aedes
dalzieli, a zoophilic vector in Africa.51
It is also possible that the link between sporadic cases of
microcephaly in Zika endemic areas were being missed due to low
numbers and poor surveillance mechanisms. Thus it was only
when the massive outbreak occurred in Brazil, which has a good
live birth surveillance system, that the link between ZIKV and
microcephaly was recognized.7,49,52
The Chikungunya Virus (CKV) responsible for the outbreak in
Italy in 2007 showed a speciﬁc mutation in the E1 gene, A226 V,
which probably increased the adaption to Aedes albopictus allowing
more efﬁcient transmission.53–55 A recent study of the Aedes
albopictus found that certain ﬂavivirus sequences were integrated
into the A. albopictus genome, indicating a long co-existence and
mutual adaptation.56
Another parallel to draw here is the introduction of West Nile
Virus to North America in 1999 which seems to be explained by
ecological and environmental factors (an abundance of suitable
vectors and a huge reservoir in non-immune birds) creating a
biological niche in a pristine environment.57 Since the introduction
the original NY99 genotype has been replaced by the SW/WN03
genotype.38Similar detailed analysis of the ZIKV which is now rapidly
spreading throughout Central and South America is now required.
6. Protecting the health of attendees of the 2016 Olympics
Given the increase of congenital anomalies, Guillain-Barre´
syndrome, other neurological and autoimmune syndromes asso-
ciated with ZIKV,5,10,50 the WHO recommends that all Member
States establish and maintain heightened awareness and capacity
to detect and conﬁrm ZIKV cases, have healthcare facilities
prepared to respond to a possible increased demand for specialized
care for microcephaly and neurological syndromes, strengthen
antenatal care, and introduce public health measures to reduce risk
of ZIKV spread and infection.4,5
6.1. Reducing risk of acquiring ZIKV
Several recommendations are available for reducing risk of
acquiring ZIKV.56–58 Measures to avoid mosquito bites61 include
wearing long sleeved shirts, use of insect repellant and staying in
screened or air conditioned accommodations. US-CDC58 and
ECDC10 recommend that any travelers who are pregnant (any
stage/ trimester) or planning to become pregnant, should avoid
travelling to areas with ZIKV outbreaks. If travel cannot be avoided
or postponed, or if people live in areas where ZIKV transmission is
known to occur, scrupulous measures to avoid mosquito bites
during both daytime and nighttime hours must be taken. Pregnant
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apply a U.S. Environmental Protection Agency (EPA)-approved
insect repellent, and sleep in a screened room or under a mosquito
net. Aedes spp mosquitoes predominantly bite during the day,
especially around dawn and dusk, and thus the correct timing and
use of mosquito repellents and other personal protection measures
are key to preventing any vector-borne infection.
6.2. Reducing other health risks
There are several other health risks that attendees of the
2016 Olympic games will face1,2 and all travelers to the 2016 Olym-
pic games should seek travel health advice from their family doctors
or a travel medicine providers, well in advance of their travel. They
should also consult the National Travel Health Network and
Centre56, the Latin American Society for Travel Medicine
(SLAMVI)58,62 guidelines or their relevant local public health agency
for up to date country information on requirements for pre-travel
vaccinations (eg Yellow Fever) and malaria prophylaxis. The CDC
issued interim guidelines the 22 January 2016 for pregnant women
visiting areas with the Zika Virus Outbreak.59,60 Travelers should
also be educated on safe eating and drinking habits such as choosing
bottled water over tap water, making sure meat and seafood are
cooked fully, and avoiding raw unpeeled fruits and vegetables, and
wearing appropriate footwear and avoiding skin contact with sand
to prevent worm infections, such as cutaneous larva migrans. Sex
education for prevention of sexually transmitted diseases and the
use of condoms is also important.
Zika virus is a blood borne disease and the infection control
precautions include meticulous hand hygiene, standard and
contact precautions (isolation, wearing gloves, water impermeable
apron, protection of mucous membranes), safe disposal of sharps
and blood and body ﬂuids when patient are admitted to, or seen at
healthcare facilities. It is particularly important that cleaning and
sterilization of medical devices which are not disposable are
carried out after each patient use.
Transmission of the arboviruses ZIKV, CKV and Dengue virus in
Brazil can occur during all months of the year.63,64 In 2014 a major
outbreak of CKV infections (>1000 cases reported), occurred in
August-and September in a completely susceptible population in
Bahia.64 This suggests the potential for transmission of ZIKV,
outside of periods typical for Dengue Virus outbreaks in a
population lacking immunity to ZIKV. The WHO5 Emergency
Committee on Zika virus has emphasized that ‘A coordinated
international response is needed to improve surveillance, the
detection of infections, congenital malformations, and neurologi-
cal complications, to intensify the control of mosquito populations,
and to expedite the development of diagnostic tests and vaccines
to protect people at risk, especially during pregnancy.’ Ongoing
vector control efforts by the Brazilian government prior to the
Games will reduce the risk of outbreaks of ZIKV and other vector
borne diseases amongst attendees and the local population. The
Brazilian authorities have in put in place intense vector control
programs which are eliminating breeding sites for Aedes spp to
prevent the spread of the ZIKV at the impending August 2016 Rio
de Janeiro Olympic Games. Brazil hosted the 2014 Fe´de´ration
Internationale de Football Association (FIFA) World Cup and the
event went without any major infectious diseases incidents.65 Our
hope is that the Olympic Games will not be plagued by infectious
diseases outbreaks, and the perceived anticipated threat of
international spread of ZIKV from Brazil66 will not materialize.
7. Conclusions
ZIKV has been present for many decades in Africa and Asia;
since 2007 it has caused major outbreaks in Micronesia, FrenchPolynesia, and recently reached Brazil in 2015. In the Americas
ZIKV is spreading and is a potential threat to the attendees of the
2016 Rio Olympics. A previously unreported linkage has been
identiﬁed in Brazil, that of microcephaly in babies and other
neurological disorders leading to the WHO declaring ZIKV a ‘Global
emergency’ Molecular analyses of ZIKV are urgently needed to
understand whether a change in the virus can explain the rapid
spread and the serious consequences of infection. In the absence of
a ZIKV vaccine, control efforts so far rests entirely on mosquito
vector control both at community and household levels and
prevention of mosquito bites by individuals. Strategies for
preventing spread by blood transfusions, via sexual contact (if
conﬁrmed), other tissue and organ transplantation and are
required. Travel restrictions to ZIKV endemic areas for pregnant
women, and postposing pregnancy for women living in areas
experiencing ZIKV outbreaks have been recommended. The
development and availability of speciﬁc and rapid diagnostic tests
for ZIKV will allow enhanced surveillance and assessing level of
risk for microcephaly, Guillain-Barre, and other complications.
There is no speciﬁc treatment or vaccine available. Research into
rapid diagnostics, treatments and vaccine are underway. The
emergence of ZIKV soon after the Ebola outbreak, is yet another
reminder for the urgent need for a coordinated Global effort to
have sufﬁciently resourced Rapid Response Groups for proactive
surveillance and conduct of priority research in emergency
situations.
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